Smartwatch AI could spot dangerous thyroid Flare-Ups

NCT ID NCT07017907

Recruiting now Diagnosis Sponsor: THYROSCOPE INC. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a software called Glandy HYPER that uses artificial intelligence to detect thyrotoxicosis—a dangerous overactive thyroid state—in people with Graves' disease. The AI analyzes resting heart rate data from wearable devices like smartwatches and compares it with standard blood tests. Researchers will enroll 15 adults with Graves' disease to see how well the software performs, but its results will not be shared with participants or affect their medical care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Heart rate-based AI software for detecting thyrotoxicosis
What this could lead to: If successful, this AI tool could offer a non-invasive way to monitor thyroid storms using wearable devices, potentially improving early detection.
What could go wrong: This is a small, early-stage study with only 15 participants, so results may not apply broadly. The software is not FDA-approved and is for research only.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Graves disease hyperthyroidism thyrotoxicosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GRAVES DISEASE HYPERTHYROIDISM/THYROTOXICOSIS

Contacts and locations

Locations

Umesh Masharani
RECRUITING

San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.